Community Health and Preventive Medicine | Digestive System Diseases | Higher Education | Male Urogenital Diseases | Medicine and Health Sciences
Prostate cancer screening is a controversial topic in the general population and is even more contested among liver transplant candidates. Not only should transplant programs be concerned about the risk of false positive screening results but also the competing risks of death and the diagnostic and therapeutic effects of true prostate cancer, which often does not cause significant morbidity or mortality in organ transplant recipients. Our letter highlights a best-practices approach to prostate cancer screening in transplant candidates using available research and consensus guidelines.
Prostate cancer; liver transplantation; screening
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Twohig, P., Schober, J., McCashland, T., , Peeraphatdit, T. To Screen or Not to Screen: Prostate Cancer in Liver Transplant Candidates. Graduate Medical Education Research Journal. 2023 Nov 21; 5(2).